{"nct_id":"NCT03222973","title":"Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)","status":"TERMINATED","status_verified_date":"2022-03","start_date":"2017-11-15","start_date_type":"ACTUAL","primary_completion_date":"2021-02-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}